Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Experimental & Molecular Medicine ; : 228-242, 2003.
Article Dans Anglais | WPRIM | ID: wpr-13862

Résumé

Transglutaminase enzymes (TGases) catalyze the calcium dependent formation of an isopeptide bond between protein-bound glutamine and lysine substrates. Previously we have shown that activated TGase 3 acquires two additional calcium ions at site two and three. The calcium ion at site three results in the opening of a channel. At this site, the channel opening and closing could modulate, depending on which metal is bound. Here we propose that the front of the channel could be used by the two substrates for enzyme reaction. We propose that the glutamine substrate is directed from Trp236 into the enzyme, shown by molecular docking. Then a lysine substrate approaches the opened active site to engage Trp327, leading to formation of the isopeptide bond. Further, direct comparisons of the structures of TGase 3 with other TGases have allowed us to identify several residues that might potentially be involved in generic and specific recognition of the glutamine and lysine substrates.


Sujets)
Animaux , Humains , Sites de fixation , Calcium/métabolisme , Protéines de liaison au calcium/métabolisme , Glutamine/métabolisme , Lysine/métabolisme , Modèles chimiques , Modèles moléculaires , Liaison aux protéines , Structure tertiaire des protéines , Transglutaminases/métabolisme
2.
Experimental & Molecular Medicine ; : 177-185, 1998.
Article Dans Anglais | WPRIM | ID: wpr-159772

Résumé

The relevance of transglutaminases with neural function and several disorders has been emphasized recently. Especially, many polypeptides associated with neurodegenerative diseases are suggested to be putative transglutaminase substrates such as beta amyloid protein of Alzheimer's disease, microtubule-associated proteins and neurofilaments, etc. In addition, the CAG repeated gene products with probable polyglutamine tract, putative transglutaminase substrates, were identified in several neurodegenerative disorders. However, the identity of the brain transglutaminase has not been confirmed, because of enzymic stability and low activity. In the present experiment, we have isolated brain-specific transglutaminases, designated as TGase NI and TGase NII, which are different from other types of transglutaminases in respects of molecular weights (mw. 45 kDa, 29 kDa respectively), substrate affinity, elution profile on ion-exchange chromatography, sensitivity to proteases and ethanol, and immunological properties. The enzymes were localized specifically in the brain tissues but not in the liver tissue. And neural cells such as pheochromocytoma cell, glioma cell, primary neuronal and glial cells were shown to be enriched with TGase NI and TGase NII. The possible biological roles of the enzymes were discussed not only on the aspect of crosslinking activity but also of signal transducing capacity of the enzyme in the brain.


Sujets)
Mâle , Rats , Animaux , Astrocytes/enzymologie , Technique de Western , Encéphale/enzymologie , Calcium/métabolisme , Chromatographie d'échange d'ions , Endopeptidases/pharmacologie , Stabilité enzymatique , Éthanol/pharmacologie , Gliome , Immunotransfert , Immunohistochimie , Masse moléculaire , Neurones/enzymologie , Cellules PC12 , Transglutaminases/isolement et purification , Transglutaminases/immunologie , Transglutaminases/composition chimique , Rat Sprague-Dawley , Trypsine/pharmacologie , Cellules cancéreuses en culture
SÉLECTION CITATIONS
Détails de la recherche